Literature DB >> 17079668

Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.

Geneviève Gowing1, Florence Dequen, Geneviève Soucy, Jean-Pierre Julien.   

Abstract

An increase in the expression of the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) has been observed in patients with amyotrophic lateral sclerosis (ALS) and in the mice models of the disease. TNF-alpha is a potent activator of macrophages and microglia and, under certain conditions, can induce or exacerbate neuronal cell death. Here, we assessed the contribution of TNF-alpha in motor neuron disease in mice overexpressing mutant superoxide dismutase 1 (SOD1) genes linked to familial ALS. This was accomplished by the generation of mice expressing SOD1(G37R) or SOD1(G93A) mutants in the context of TNF-alpha gene knock out. Surprisingly, the absence of TNF-alpha did not affect the lifespan or the extent of motor neuron loss in SOD1 transgenic mice. These results provide compelling evidence indicating that TNF-alpha does not directly contribute to motor neuron degeneration caused by SOD1 mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079668      PMCID: PMC6674545          DOI: 10.1523/JNEUROSCI.0602-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1.

Authors:  J Aebischer; P Cassina; B Otsmane; A Moumen; D Seilhean; V Meininger; L Barbeito; B Pettmann; C Raoul
Journal:  Cell Death Differ       Date:  2010-11-12       Impact factor: 15.828

Review 2.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

Review 3.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease.

Authors:  Christian S Lobsiger; Don W Cleveland
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

Review 4.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 5.  Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.

Authors:  Kristopher G Hooten; David R Beers; Weihua Zhao; Stanley H Appel
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.

Authors:  Ashley E Frakes; Laura Ferraiuolo; Amanda M Haidet-Phillips; Leah Schmelzer; Lyndsey Braun; Carlos J Miranda; Katherine J Ladner; Adam K Bevan; Kevin D Foust; Jonathan P Godbout; Phillip G Popovich; Denis C Guttridge; Brian K Kaspar
Journal:  Neuron       Date:  2014-03-05       Impact factor: 17.173

7.  Glial-derived prodegenerative signaling in the Drosophila neuromuscular system.

Authors:  Lani C Keller; Ling Cheng; Cody J Locke; Martin Müller; Richard D Fetter; Graeme W Davis
Journal:  Neuron       Date:  2011-12-08       Impact factor: 17.173

8.  Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial.

Authors:  Elijah W Stommel; Jeffrey A Cohen; Camilo E Fadul; Christopher H Cogbill; David J Graber; Linda Kingman; Todd Mackenzie; Jacqueline Y Channon Smith; Brent T Harris
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

9.  TNF-α triggers rapid membrane insertion of Ca(2+) permeable AMPA receptors into adult motor neurons and enhances their susceptibility to slow excitotoxic injury.

Authors:  Hong Z Yin; Cheng-I Hsu; Stephen Yu; Shyam D Rao; Linda S Sorkin; John H Weiss
Journal:  Exp Neurol       Date:  2012-08-19       Impact factor: 5.330

Review 10.  The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?

Authors:  Kevin R Doty; Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  Brain Res       Date:  2014-09-08       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.